Breast CancerPhase 2NCT00473122
Delayed-Immediate Breast Reconstruction
A Phase 2 study testing Delayed-Immediate Breast Reconstruction in people with Breast Cancer, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
The goal of this clinical research study is to evaluate a new two-stage approach (delayed-immediate reconstruction) to breast reconstruction in women who may require post-mastectomy radiation therapy. Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Breast Cancer
- What is being tested?
- Delayed-Immediate Breast Reconstruction
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2005to Aug 2015
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients with clinical stage I or stage II breast cancer who may require postmastectomy XRT.
- Patients will be required to receive postmastectomy XRT as well as breast reconstructive procedures, including subsequent deflation and re-inflation of the prosthesis after XRT at University of Texas MD Anderson Cancer Center (UT MDACC).
- Patients must sign the consent form and must be able to withstand two (2) anesthetic procedures.
- Patients with stage I breast cancer who will be eligible for delayed-immediate breast reconstruction will have extensive microcalcifications within the affected by mammography that make it difficult to determine preoperatively the extent of invasive disease.
Who cannot join
- Patients with stage III or stage IV breast cancer who are known preoperatively to require postmastectomy XRT.
- Patients with stage I breast cancer who are unlikely to require postmastectomy XRT.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
About this study
The goal of this clinical research study is to evaluate a new two-stage approach (delayed-immediate reconstruction) to breast reconstruction in women who may require post-mastectomy radiation therapy. Researchers will compare the cosmetic outcomes and any complications that occur in women who receive delayed-immediate reconstruction to those who receive the standard approaches (either immediate reconstruction or delayed breast reconstruction).
Read the detailed description
In women who have a mastectomy and desire breast reconstruction, the best timing of breast reconstruction depends on whether radiation therapy (XRT) is needed. If XRT is not needed, immediate reconstruction offers the best cosmetic result. However, if XRT is needed, it is better to delay reconstruction until XRT is complete. There are 2 reasons to wait. First, the presence of a reconstructed breast can interfere with the delivery of XRT, decreasing the effectiveness of this treatment. Second, exposing a reconstructed breast to radiation can cause poor cosmetic results. Today, many women are not offered immediate reconstruction because it is not known at the time of their mastectomy whether they will need XRT. Researchers believe that for such women, a new approach called "delayed-immediate reconstruction" will offer the cosmetic benefits of immediate reconstruction without the potential drawbacks of ineffective treatment.
If you agree to take part in this study, you will have your already scheduled skin-sparing mastectomy. However, at the time of your routine mastectomy, you will also have a tissue expander or postoperatively adjustable implant (fully inflated with saline or as allowed by the remaining capacity [space] of the retained breast skin) placed in your breast. Some patients will have a small biopsy of skin, that is normally discarded, done so that scientists can learn about changes and ways of healing after radiation. When the final pathology report is complete (about 1 week after mastectomy), the radiation doctor and/or your surgeon will decide whether or not you need XRT.
If the results show that you do not need XRT, you will have the tissue expander or implant removed and will have standard definitive breast reconstruction, using the preserved breast skin about 2 weeks after mastectomy. The reconstructive technique used will be decided based on anatomical considerations, surgical factors, and your personal desires. The postoperative follow-up will be similar to that of patients who have standard immediate breast reconstruction.
If the results show that you do need XRT, the tissue expander or adjustable implant will be completely deflated in the plastic surgery clinic before you receive standard XRT. Radiation must be given either at MD Anderson or an MD Anderson-affiliated site. Deflation of the tissue expander or implant will result in a flat chest wall that will decrease difficulties with radiation delivery that can occur after an immediate breast reconstruction. If you also require chemotherapy after mastectomy, the tissue expander or implant will remain inflated during chemotherapy (additional saline-filling may also be performed during chemotherapy, if required). In patients who have already received chemotherapy before mastectomy or who will not require chemotherapy, the expander or implant will remain inflated during the 4-to-6-week period between mastectomy and XRT. About 3 weeks into your radiation treatments, you will come in to the plastic surgery clinic for a follow-up to check on the status of the implants.
Several weeks after the completion of XRT, the tissue expander or postoperatively adjustable implant will be gradually re-expanded over about 6-months. The internal scar capsule that forms around the tissue expander or implant before deflation usually allows for re-expansion after radiation therapy. Re-expansion after radiation therapy will be performed during postoperative visits to the plastic surgery clinic every 2-to-4 weeks until the desired size is achieved. About 6 months after the completion of XRT, a "skin-preserving" delayed reconstruction with a preference for autologous tissues only (no breast implants) will be performed. This will involve removal of the tissue expander or implant and definitive breast reconstruction. At the time of the skin-preserving delayed reconstruction, a small biopsy of usually thrown away radiated breast tissue as well as a sample of the skin, that is normally discarded, of the flap (your tissue that is taken from your back, stomach or buttock to build the breast) and a sample of the implant or tissue expander will be collected for laboratory evaluation. Researchers will evaluate the skin changes from radiation and expansion as well as from the internal scar capsule. This will be compared to radiated skin biopsies without expansion and biopsies taken after skin expansion without radiation.
Your medical information and photographs of your breast(s) will be gathered throughout the various stages of delayed-immediate reconstruction.
Delayed-immediate breast reconstruction is a two-stage approach and as such involves at least 2 surgical procedures. This does not include the possibility of procedures needed to modify the reconstructed breast, a procedure on the healthy breast to make it symmetrical (similar in appearance and size) with the reconstructed breast, and any nipple reconstruction and areolar tattooing that may be needed. If, later on, it is necessary to revise the reconstructed breast, a small skin sample (smaller than a pencil eraser) will again be collected for additional studies. This will not affect the outcome of your surgery or the way your breast will look.
The postoperative course, follow-up, and the need for additional surgical procedures will be decided in a similar fashion to that of standard immediate and delayed breast reconstruction.
This is an investigational study. The implants in this study have been FDA approved for skin expansion as a method of breast reconstruction. They are not specifically approved for both expansion and radiation. About 200 women will take part in this study. All will be enrolled at MD Anderson Cancer Center (MDACC).
- Conditions
- Breast Cancer
- Being tested
- Delayed-Immediate Breast Reconstruction
- Keywords
- Breast Cancer, Breast Reconstruction, Delayed-Immediate Reconstruction, Postmastectomy Radiation Therapy, Mastectomy, XRT
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Delayed-Immediate Breast ReconstructionProcedure or surgery
Immediate reconstruction surgery if no XRT required; or reconstruction surgery delayed until XRT complete.
| Study group | Role | What they receive |
|---|---|---|
| Delayed-Immediate Breast Reconstruction | Other | Delayed-Immediate Reconstruction: If radiation therapy (XRT) not needed, immediate reconstruction. If XRT is needed, delayed reconstruction until XRT complete. Receives: Procedure: Delayed-Immediate Breast Reconstruction |
What is being measured
The primary outcome is the main question the study is designed to answer.
Efficacy of Delayed-Immediate Breast Reconstruction
Patient data and photographs gathered throughout the various stages of delayed-immediate reconstruction, during routine preoperative, intraoperative, and postoperative examinations. Details of primary disease include preoperative tumor stage, method of breast cancer diagnosis, tumor biologic characteristics, and the use of neoadjuvant chemotherapy. Preoperative and postoperative tumor stage compared to evaluate the indications for the delayed-immediate approach to breast reconstruction.
Measured: 5 Years
Secondary outcomes (1)
Compare Aesthetic Outcomes for Immediate-Delayed Breast Reconstruction
System used for aesthetic analysis is a four-point scale used to evaluate the aesthetic outcomes: excellent (4); good (3); fair (2); or poor (1). Results considered "excellent" when patient had almost perfect shape of the reconstructed breast and perfect contralateral breast symmetry, "good" when patient had imperfect shape of the reconstructed breast and imperfect contralateral symmetry but within normal limits, "fair" when patient had some contralateral asymmetry but a reasonably normal breast, and "poor" when patient had unacceptable shape and symmetry.
Measured: 5 Years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2007 (estimated)
- Study startApr 2005
- Primary completionAug 2015
- Study completionAug 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- Susan G. Komen Breast Cancer Foundation
- Responsible party
- Sponsor
- Investigators
- Steven J. Kronowitz, MD, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00473122
- Sponsor's protocol ID
- 2004-0955
- Other IDs
- NCI-2012-02091, BCTR0503938
- Status last verified
- Jul 2016
- First submitted
- 10 May 2007
- Last updated
- 15 Jul 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Delayed-Immediate Breast Reconstruction
- ClinicalTrials.gov ID
- NCT00473122
- Acronym / sponsor ID
- 2004-0955
- Conditions
- Breast Cancer
- Keywords
- Breast Cancer, Breast Reconstruction, Delayed-Immediate Reconstruction, Postmastectomy Radiation Therapy, Mastectomy, XRT
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Collaborators
- Susan G. Komen Breast Cancer Foundation
- Study start
- Apr 2005
- Primary completion
- Aug 2015 (actual)
- Study completion
- Aug 2015 (actual)
- First posted
- 14 May 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical research study is to evaluate a new two-stage approach (delayed-immediate reconstruction) to breast reconstruction in women who may require post-mastectomy radiation therapy. Researchers will compare the cosmetic outcomes and any complications that occur in women who receive delayed-immediate reconstruction to those who receive the standard approaches (either immediate reconstruction or delayed breast reconstruction).
Detailed description
In women who have a mastectomy and desire breast reconstruction, the best timing of breast reconstruction depends on whether radiation therapy (XRT) is needed. If XRT is not needed, immediate reconstruction offers the best cosmetic result. However, if XRT is needed, it is better to delay reconstruction until XRT is complete. There are 2 reasons to wait. First, the presence of a reconstructed breast can interfere with the delivery of XRT, decreasing the effectiveness of this treatment. Second, exposing a reconstructed breast to radiation can cause poor cosmetic results. Today, many women are not offered immediate reconstruction because it is not known at the time of their mastectomy whether they will need XRT. Researchers believe that for such women, a new approach called "delayed-immediate reconstruction" will offer the cosmetic benefits of immediate reconstruction without the potential drawbacks of ineffective treatment.
If you agree to take part in this study, you will have your already scheduled skin-sparing mastectomy. However, at the time of your routine mastectomy, you will also have a tissue expander or postoperatively adjustable implant (fully inflated with saline or as allowed by the remaining capacity [space] of the retained breast skin) placed in your breast. Some patients will have a small biopsy of skin, that is normally discarded, done so that scientists can learn about changes and ways of healing after radiation. When the final pathology report is complete (about 1 week after mastectomy), the radiation doctor and/or your surgeon will decide whether or not you need XRT.
If the results show that you do not need XRT, you will have the tissue expander or implant removed and will have standard definitive breast reconstruction, using the preserved breast skin about 2 weeks after mastectomy. The reconstructive technique used will be decided based on anatomical considerations, surgical factors, and your personal desires. The postoperative follow-up will be similar to that of patients who have standard immediate breast reconstruction.
If the results show that you do need XRT, the tissue expander or adjustable implant will be completely deflated in the plastic surgery clinic before you receive standard XRT. Radiation must be given either at MD Anderson or an MD Anderson-affiliated site. Deflation of the tissue expander or implant will result in a flat chest wall that will decrease difficulties with radiation delivery that can occur after an immediate breast reconstruction. If you also require chemotherapy after mastectomy, the tissue expander or implant will remain inflated during chemotherapy (additional saline-filling may also be performed during chemotherapy, if required). In patients who have already received chemotherapy before mastectomy or who will not require chemotherapy, the expander or implant will remain inflated during the 4-to-6-week period between mastectomy and XRT. About 3 weeks into your radiation treatments, you will come in to the plastic surgery clinic for a follow-up to check on the status of the implants.
Several weeks after the completion of XRT, the tissue expander or postoperatively adjustable implant will be gradually re-expanded over about 6-months. The internal scar capsule that forms around the tissue expander or implant before deflation usually allows for re-expansion after radiation therapy. Re-expansion after radiation therapy will be performed during postoperative visits to the plastic surgery clinic every 2-to-4 weeks until the desired size is achieved. About 6 months after the completion of XRT, a "skin-preserving" delayed reconstruction with a preference for autologous tissues only (no breast implants) will be performed. This will involve removal of the tissue expander or implant and definitive breast reconstruction. At the time of the skin-preserving delayed reconstruction, a small biopsy of usually thrown away radiated breast tissue as well as a sample of the skin, that is normally discarded, of the flap (your tissue that is taken from your back, stomach or buttock to build the breast) and a sample of the implant or tissue expander will be collected for laboratory evaluation. Researchers will evaluate the skin changes from radiation and expansion as well as from the internal scar capsule. This will be compared to radiated skin biopsies without expansion and biopsies taken after skin expansion without radiation.
Your medical information and photographs of your breast(s) will be gathered throughout the various stages of delayed-immediate reconstruction.
Delayed-immediate breast reconstruction is a two-stage approach and as such involves at least 2 surgical procedures. This does not include the possibility of procedures needed to modify the reconstructed breast, a procedure on the healthy breast to make it symmetrical (similar in appearance and size) with the reconstructed breast, and any nipple reconstruction and areolar tattooing that may be needed. If, later on, it is necessary to revise the reconstructed breast, a small skin sample (smaller than a pencil eraser) will again be collected for additional studies. This will not affect the outcome of your surgery or the way your breast will look.
The postoperative course, follow-up, and the need for additional surgical procedures will be decided in a similar fashion to that of standard immediate and delayed breast reconstruction.
This is an investigational study. The implants in this study have been FDA approved for skin expansion as a method of breast reconstruction. They are not specifically approved for both expansion and radiation. About 200 women will take part in this study. All will be enrolled at MD Anderson Cancer Center (MDACC).
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Delayed-Immediate Breast Reconstruction | Other | Procedure: Delayed-Immediate Breast ReconstructionDelayed-Immediate Reconstruction: If radiation therapy (XRT) not needed, immediate reconstruction. If XRT is needed, delayed reconstruction until XRT complete. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (4 listed)
- Patients with clinical stage I or stage II breast cancer who may require postmastectomy XRT.
- Patients will be required to receive postmastectomy XRT as well as breast reconstructive procedures, including subsequent deflation and re-inflation of the prosthesis after XRT at University of Texas MD Anderson Cancer Center (UT MDACC).
- Patients must sign the consent form and must be able to withstand two (2) anesthetic procedures.
- Patients with stage I breast cancer who will be eligible for delayed-immediate breast reconstruction will have extensive microcalcifications within the affected by mammography that make it difficult to determine preoperatively the extent of invasive disease.
Key exclusion criteria (2 listed)
- Patients with stage III or stage IV breast cancer who are known preoperatively to require postmastectomy XRT.
- Patients with stage I breast cancer who are unlikely to require postmastectomy XRT.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Delayed-Immediate Breast ReconstructionImmediate reconstruction surgery if no XRT required; or reconstruction surgery delayed until XRT complete. | Procedure or surgery | Delayed-Immediate Breast Reconstruction |
Primary outcome
Efficacy of Delayed-Immediate Breast Reconstruction
Time frame: 5 Years
Patient data and photographs gathered throughout the various stages of delayed-immediate reconstruction, during routine preoperative, intraoperative, and postoperative examinations. Details of primary disease include preoperative tumor stage, method of breast cancer diagnosis, tumor biologic characteristics, and the use of neoadjuvant chemotherapy. Preoperative and postoperative tumor stage compared to evaluate the indications for the delayed-immediate approach to breast reconstruction.
1 secondary outcome
Compare Aesthetic Outcomes for Immediate-Delayed Breast Reconstruction
Time frame: 5 Years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2016.
- University of Texas MD Anderson Cancer Center WebsiteLink provided by the sponsor.
Related trials for Breast Cancer
Active, not recruitingPhase 2
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7
RecruitingPhase 1/2
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer
Not yet recruiting
Podcast-Based Psychosocial Support for Women Newly Diagnosed With Breast Cancer
Breast Cancer
Recruiting
A Study of Skipping Radiation Therapy in People With Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Active, not recruiting
Dance Study for Post-surgical Pain in Breast Cancer Survivors
Breast Cancer, Survivorship
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Steven J. Kronowitz, MD principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Delayed-Immediate Breast Reconstruction in people with Breast Cancer, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Efficacy of Delayed-Immediate Breast Reconstruction (time frame: 5 Years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2016.